These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18588519)

  • 1. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008.
    Slavin MA
    Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the treatment of established fungal infections.
    Thursky KA; Playford EG; Seymour JF; Sorrell TC; Ellis DH; Guy SD; Gilroy N; Chu J; Shaw DR
    Intern Med J; 2008 Jun; 38(6b):496-520. PubMed ID: 18588522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.
    Slavin MA; Thursky KA; Worth LJ; Chang CC; Morrissey CO; Blyth CC; Chen SC; Szer J
    Intern Med J; 2014 Dec; 44(12b):1267-76. PubMed ID: 25482739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal infections in onco-haematology: a Spanish perspective.
    Rev Esp Quimioter; 2011 Sep; 24(3):168-72. PubMed ID: 21947102
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifungal therapy in 'bone marrow failure'.
    Richardson MD; Kokki MH
    Br J Haematol; 1998 Mar; 100(4):619-28. PubMed ID: 9531326
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infections in neutropenic patients].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
    García-Ruiz JC; Pontón J
    Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is it possible to prevent mycotic infections in oncology patients?].
    Mayer J; Vorlícek J
    Vnitr Lek; 1994 Dec; 40(12):783-8. PubMed ID: 7839633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of infections caused by opportunistic agents: fungi].
    Martín E; Nogales MC; Flórez C; Vargas J; Sánchez A
    Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():62-6. PubMed ID: 2490490
    [No Abstract]   [Full Text] [Related]  

  • 12. Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.
    van Hal SJ; Gilroy NM; Morrissey CO; Worth LJ; Szer J; Tam CS; Chen SC; Thursky KA; Slavin MA
    Intern Med J; 2014 Dec; 44(12b):1277-82. PubMed ID: 25482740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infections in patients with cancer.
    Anaissie EJ; Bodey GP
    Pharmacotherapy; 1990; 10(6 ( Pt 3)):164S-169S. PubMed ID: 2075117
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventative use of antifungal drugs in patients treated for cancer.
    de Pauw B
    J Antimicrob Chemother; 2004 Feb; 53(2):130-2. PubMed ID: 14729743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America.
    Sobel JD
    Clin Infect Dis; 2000 Apr; 30(4):652. PubMed ID: 10770725
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.
    Taçyildiz N; Yavuz G; Unal E; Gözdasoğlu S; Ertem M; Aysev D
    Med Pediatr Oncol; 1999 Dec; 33(6):596-7. PubMed ID: 10573590
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders.
    Worth LJ; Blyth CC; Booth DL; Kong DC; Marriott D; Cassumbhoy M; Ray J; Slavin MA; Wilkes JR
    Intern Med J; 2008 Jun; 38(6b):521-37. PubMed ID: 18588523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of systemic Fusarium infection in children with leukemia.
    Ariffin H; Ariffin W; Mohamed M; Arasu A; Peng LH
    Med Pediatr Oncol; 1999 Dec; 33(6):598-9. PubMed ID: 10573592
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated guidelines for managing fungal diseases in hematology patients.
    Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.